TB-500

TB-500 in Laboratory Research

TB-500 corresponds to the active N-terminal region of Thymosin Beta-4, a 43-residue protein that is the dominant actin-binding species in most mammalian cell types. The shortened fragment retains the actin-binding motif while being far simpler to synthesise and handle.

In controlled laboratory environments, research groups use TB-500 as a defined tool for manipulating cytoskeletal dynamics under experimental conditions.

Research Applications & Study Focus

The peptide appears frequently in actin-polymerisation assays, cell-migration and scratch-closure models, angiogenesis preparations, and cardiac-remodelling research where cytoskeletal dynamics are the variable of interest.

Its consistent lot specification supports reproducible migration and cytoskeletal endpoints across repeated experiments.

Purity, Handling & Verification

Each batch is supplied as a sealed, lyophilized vial and is independently analysed by a third-party laboratory using HPLC and mass spectrometry; the full certificate of analysis is published against its lot number, so results can be verified before use. Store the lyophilized material cool, dry and out of direct light, and reconstitute with bacteriostatic water under standard aseptic laboratory practice.

This material is offered strictly for in vitro laboratory research use only. It is not for human or veterinary consumption, and not for diagnostic or therapeutic use.